3.1 Contrast Media Properties, Osmolality & Safety
Key Takeaways
Iodine’s K edge is about 33.17 keV. A tube voltage describes the upper limit of a spectrum used for imaging.
Ionicity, osmolality and viscosity answer different questions. Read the specific concentration and formulation on the label.
Iodine delivery rate equals concentration times actual flow. Compute the iodine mass for each run from its concentration and delivered volume.
Warming can reduce viscosity by an agent-specific amount. The permitted product handling and equipment limits apply to the injection.
Carbon dioxide use depends on anatomy, patient factors and dedicated delivery. Gadolinium risk and indication depend on the agent and imaging route.
3.1 Contrast Media Properties, Osmolality & Safety
Clinical Core: Iodinated contrast increases X-ray attenuation. Select and prepare the labeled formulation with attention to the required iodine delivery, injection mechanics and the patient's history. Carbon dioxide can provide negative contrast in selected vascular beds and requires different equipment and anatomy checks.
Iodine, beam energy and visible contrast
An iodinated monomer contains one ring with three iodine atoms, typically at positions 2, 4 and 6. A dimer links two such rings. Side chains affect properties such as water solubility and whether the compound ionizes. In an angiogram, iodine in the lumen attenuates more X-rays than the surrounding tissue. Digital subtraction angiography emphasizes the transient change from the mask image.
The K edge is an abrupt increase in attenuation when photon energy reaches the K-shell binding energy. NIST gives that threshold for iodine as about 33.17 keV. Away from edges, photoelectric interaction strongly favors higher atomic number and decreases as photon energy rises. Tube peak voltage sets the maximum photon energy in a broad spectrum. Filtration, patient thickness and the acquisition mode affect the spectrum at the detector. Optimize visibility and dose for the actual field and equipment.
Concentration, delivery rate and total iodine
The bottle concentration is expressed in mg iodine per mL (mg I/mL). At constant flow, iodine delivery per second equals concentration times flow. Total iodine administered is concentration times the contrast volume given. When different concentrations were used, calculate each run separately before adding the totals.
Worked comparison. An example 6 mL delivery at 300 mg I/mL contains mg iodine. At an actual constant flow of 3 mL/s the same delivery takes 2 seconds, and its iodine delivery rate is 900 mg I/s. The product label and the anatomical target determine which concentrations are suited to a given indication. Position, dilution, injection shape and acquisition timing affect opacification even at the same total iodine.
Osmolality, ionicity and viscosity
Osmolality counts dissolved osmotic particles per kilogram of solvent. Osmolarity uses liters of solution. Ionicity describes dissociation into charged species, and viscosity describes resistance to flow. In the simplified iodine-to-particle ratio, count particles derived from the contrast compound. A monomer stays intact if nonionic and dissociates into two charged species if ionic. Trace additives and other solutes also contribute to measured formulation osmolality.
| Formulation example | Structure and nominal ratio | Labeled osmolality |
|---|---|---|
| Iothalamate meglumine, Conray | High-osmolality ionic monomer, 3 iodine atoms per 2 particles | Approximately 1,400 mOsm/kg |
| Iopamidol, Isovue 300 and 370 | Low-osmolality nonionic monomer, 3 iodine atoms per particle | 616 and 796 mOsm/kg, respectively, at 37°C |
| Iodixanol, Visipaque 270 and 320 | Iso-osmolality nonionic dimer, 6 iodine atoms per particle | 290 mOsm/kg, near plasma osmolality |
Historical ioxaglate is an example of a low-osmolality ionic dimer. Its six iodine atoms are paired with two solute particles after dissociation. High-osmolality products can cause larger osmotic shifts. Modern IV practice generally uses low- or iso-osmolality agents. The Conray label still lists specific intravascular uses and prohibits intrathecal use. ACR–NKF finds no established clinically relevant kidney risk difference between low- and iso-osmolality agents for IV use. Intra-arterial decisions require separate consideration of the procedure and patient. The reaction-management lesson develops that distinction.
Warming and delivery pressure
The ACR discusses warming for selected circumstances, including viscous iodinated media and direct arterial injection through small catheters. U.S. Isovue labeling permits room or body temperature administration. In its Table 7, Isovue 370 has viscosity 20.9 cP at 20°C and 9.4 cP at 37°C. This is a drop of about 55% for that formulation across those temperatures. The same label gives 3.3 and 2.0 cP for Isovue 200, a drop of about 39%.
An ideal straight tube with laminar flow needs more pressure at a fixed flow when the fluid has greater viscosity. The power injector lesson explains why real delivery also depends on the internal lumen, circuit, changing flow, pressure limit and label. A warmer may reduce pressure demand. Check permitted storage and warming as well as the catheter and tubing limits before selecting the prescribed settings.
Carbon dioxide angiography
Medical-grade carbon dioxide displaces blood and produces negative contrast. Its low X-ray attenuation makes a gas-filled segment radiolucent, and subtraction software can display that segment as a vessel image. Carbon dioxide is buoyant, so a run can underfill a dependent branch. Image timing and, where supported, image stacking can help depict the path of a series of bubbles.
| Setup issue | Implication |
|---|---|
| Vascular territory | Selected infradiaphragmatic arterial studies and certain venous studies can use CO₂. Arterial use above the diaphragm risks cerebral or coronary gas events. |
| Patient and anesthetic factors | Published ESUR CO₂ guidance lists respiratory failure, pulmonary arteriovenous malformations and nitrous oxide anesthesia among contraindications. Pulmonary hypertension, chronic obstructive pulmonary disease and known intracardiac shunts require specific review. |
| Position | Buoyancy affects what fills. The ESUR document also flags abdominal aortic injection with the patient prone or the head elevated. Confirm the actual target and positioning plan. |
| Delivery | Use a dedicated gas delivery system and its checks for air exclusion, control of gas volume or pressure, and safe connection. Accidental room air delivery can cause gas embolism. |
| Dosing and monitoring | Use a procedure- and patient-specific plan for volume and interval, allowing enough time for gas clearance. Monitor the patient and report unexpected pain, pressure changes or other deterioration. |
CO₂ can reduce iodinated contrast exposure. Kidney injury can still occur after the procedure for other reasons. In a patient with suspected life-threatening gas embolism, stop further entry and activate emergency support, as described in the emergency lesson. That response applies to clinical deterioration and has a different purpose from positioning for an ordered image acquisition.
Gadolinium-based agents and X-ray angiography
The U.S. Gadavist label describes intravenous use for specified magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) indications. Intra-arterial use for X-ray angiography is off-label. Published coronary case experience includes significant arrhythmia and does not establish a routine substitute or a universal safe dose. Nephrogenic systemic fibrosis (NSF) risk depends on the agent group and renal status. The very low risk for ACR group II agents in indicated IV MRI applies to that setting. Review the contrast reaction, kidney risk, and available imaging alternatives with the clinical team before preparing the selected agent.
Which labeled intravascular product is a nonionic dimer with six iodine atoms per contrast-derived particle and an osmolality of about 290 mOsm/kg?
Iodixanol
Iothalamate meglumine
Ioxaglate
Iopamidol
At the same planned flow and catheter setup, what changes when Isovue 370 is warmed from 20°C to 37°C within its labeled conditions?
Iodine’s K edge shifts toward the mean beam energy.
Viscosity falls, so less pressure may be needed for the same flow. The catheter and circuit ratings still apply.
The formulation becomes iso-osmolal with plasma.
The catheter’s manufacturer-rated pressure increases.
A team is considering intra-arterial carbon dioxide angiography to reduce iodinated contrast exposure. Which intended vascular region must be ruled out because of the risk of cerebral or coronary gas embolization?
The infrarenal aorta and common iliac arteries.
The femoropopliteal arteries and distal leg runoff.
The thoracic aorta and its supra-aortic arterial branches.
The renal arteries arising from the abdominal aorta.
Sections you finish are checked off in the contents.